Head of Serum Institute said – Kovid-19 vaccine will be available for everyone till the end of 2024

The Serum Institute has tied up with 5 international pharmaceutical companies, including AstraZeneca and Novavax. The Serum Institute is engaged in developing a Coronavirus Vaccine, with 1 billion doses to be prepared. It has been promised that 50% of this will be for India.

new Delhi. Heading to the world’s largest manufacturer of vaccines, the head of the world’s largest manufacturer of vaccines said that by the end of this year, Covid-19 Vaccine is becoming available to everyone. Coronavirus Vaccine will not be able to be given to everyone before the end. In an interview to the Financial Times, Adar Poonawalla, the head of Serum Institute of India, said that the pharmaceutical companies have not increased production rapidly, causing the entire population of the world to get vaccinated in a short time. To be applied. Poonawala said, “It will take four to five years for everyone on this earth to get the vaccine.”

Adar Poonawalla had earlier said that if two doses of coronavirus vaccine were given to every human being, as in the case of Measles or Rotavirus, then the world would get 15 Arab doses will be needed.

Serum Institute promises 50% of corona vaccine doses prepared will be for India
A family-dominated serum institute, based in Pune, has tied up with 5 international pharmaceutical companies in the world, including AstraZeneca and Novavax. The Serum Institute is developing a vaccine, with 1 billion doses to be prepared. It has been promised that 50% of this will be for India. The company may also collaborate with Russia’s Gamalaya Research Institute to produce the Sputnik vaccine.
Given that Serum Institute is making vaccines for most of the developing world, Poonawalla’s comment about the manufacture and distribution of the vaccine is important. Apart from this, his statements have raised doubts about such claims of many political leaders who had committed to bring the vaccine by next month. Meanwhile, there was also a concern that as a result of large orders already placed by Europe and America, developing countries would be placed at the bottom of the list of vaccines.